Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation.

Zuercher E, Butticaz C, Wyniger J, Martinez R, Battegay M, Boffi El Amari E, Dang T, Egger JF, Fehr J, Mueller-Garamvögyi E, Parini A, Schaefer SC, Schoeni-Affolter F, Thurnheer C, Tinguely M, Telenti A, Rothenberger S; Swiss HIV Cohort Study.

PLoS One. 2012;7(2):e32168. doi: 10.1371/journal.pone.0032168. Epub 2012 Feb 22.

2.

Promoter polymorphisms and allelic imbalance in ABCB1 expression.

Loeuillet C, Weale M, Deutsch S, Rotger M, Soranzo N, Wyniger J, Lettre G, Dupré Y, Thuillard D, Beckmann JS, Antonarakis SE, Goldstein DB, Telenti A.

Pharmacogenet Genomics. 2007 Nov;17(11):951-9.

PMID:
18075465
3.

A whole-genome association study of major determinants for host control of HIV-1.

Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, Cozzi-Lepri A, De Luca A, Easterbrook P, Francioli P, Mallal S, Martinez-Picado J, Miro JM, Obel N, Smith JP, Wyniger J, Descombes P, Antonarakis SE, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Goldstein DB.

Science. 2007 Aug 17;317(5840):944-7. Epub 2007 Jul 19.

4.

Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation.

Butticaz C, Michielin O, Wyniger J, Telenti A, Rothenberger S.

J Virol. 2007 Feb;81(3):1502-5. Epub 2006 Nov 22.

5.

Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans.

Beauvais A, Monod M, Wyniger J, Debeaupuis JP, Grouzmann E, Brakch N, Svab J, Hovanessian AG, Latgé JP.

Infect Immun. 1997 Aug;65(8):3042-7.

6.

Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells.

Lahm H, Amstad P, Yilmaz A, Borbenyi Z, Wyniger J, Fischer JR, Suardet L, Givel JC, Odartchenko N.

Cell Growth Differ. 1995 Sep;6(9):1111-8.

7.

Growth inhibition of human colorectal-carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptors.

Lahm H, Schnyder B, Wyniger J, Borbenyi Z, Yilmaz A, Car BD, Fischer JR, Givel JC, Ryffel B.

Int J Cancer. 1994 Nov 1;59(3):440-7.

PMID:
7927955
8.

Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop.

Lahm H, Amstad P, Wyniger J, Yilmaz A, Fischer JR, Schreyer M, Givel JC.

Int J Cancer. 1994 Aug 1;58(3):452-9.

PMID:
8050827
9.

Secretion of bioactive granulocyte-macrophage colony-stimulating factor by human colorectal carcinoma cells.

Lahm H, Wyniger J, Hertig S, Yilmaz A, Fischer JR, Givel JC, Odartchenko N.

Cancer Res. 1994 Jul 15;54(14):3700-2.

Supplemental Content

Loading ...
Support Center